Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Remedium Lifecare has informed that the Company has received a multi-year supply contract from a pharmaceutical distribution company based in the United Kingdom. The contract involves the supply of various Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty Chemicals. The supplies scheduled between July 2024 and June 2025 alone are valued at one hundred seventy-five crore rupees. Pursuant to SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015, Disclosure given as Annexure A.
| Company Name | CMP |
|---|---|
| Redington | 226.00 |
| Adani Enterprises | 2233.60 |
| Amrapali Industries | 17.30 |
| Rashi Peripheral | 474.55 |
| PDS | 290.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: